alexa Camel Milk as Adjuvant to Treat Alloxan Diabetes: Effect of Heat Treatment on this Property | OMICS International
ISSN: 2155-6156
Journal of Diabetes & Metabolism
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Camel Milk as Adjuvant to Treat Alloxan Diabetes: Effect of Heat Treatment on this Property

Amel Sboui1,2*, Touhami Khorchani1, Mongi Djegham2, Aroua Agrebi2,3, Amel Dalleli2 and Omrane Belhadj3

1Livestock and Wildlife Laboratory, Arid Land Institute, route Edjorf, Elfgè, 4119, Medenine, Tunisia

2Physiology and Therapeutic Laboratory, Tunisian Veterinary School of medicine, 2020, Sidi Thabet, Tunisia

3Biochemistry and Techno biology Laboratory, Department of Biology, College of Sciences, Tunis El-Manar, Tunisia

*Corresponding Author:
Amel Sboui
Livestock and Wildlife Laboratory
Arid Land Institute, route Edjorf
Elfgè 4119, Medenine, Tunisia
Tel: +216.23.385.201
E-mail: [email protected]

Received date: January 21, 2012; Accepted date: May 29, 2012; Published date: June 03, 2012

Citation: Sboui A, Khorchani T, Djegham M, Agrebi A, Dalleli A, et al. (2012) Camel Milk as Adjuvant to Treat Alloxan Diabetes: Effect of Heat Treatment on this Property. J Diabetes Metab 3:190. doi:10.4172/2155-6156.1000190

Copyright: © 2012 Sboui A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Diabetes & Metabolism


Camel milk; Heat treatment; Diabetes; Dogs; Alloxan


Diabetes mellitus is one of the most common endocrine diseases in dogs. Type I of diabetes is caused by the lack of insulin and results from the destruction of the insulin-producing beta cells in the pancreas [1].

This metabolic disorder can be caused chemically using many components such as Alloxan and streptozotocine. Alloxanic diabetes is caused by the selective pancreatic beta cell toxicity of this composite [2,3]. Several species were sensitive to Alloxan toxicity such as rats, rabbit and dogs [4,5].

The pharmaceutical drugs used in diabetic therapy are either too expensive or have undesirable side-effects or contraindications [6]. Therefore, the search for more effective and safer hypoglycaemic agents has continued to be an area of active research [7,8]. In arid regions, camel milk is described for its usefulness to treat diabetes mellitus. In the same way, an Indian study has reported a hypoglycaemic effect of camel milk on diabetic rats [9].

This research was conducted to verify the effect of camel milk in diabetic dogs in comparison to cow milk and to follow the efficiency of this effect after heat treatment of milk (pasteurized and boiled camel milk).

Alloxan-diabetic dog was used because it is a model of partial insulin deficiency and insulin resistance while simulating postprandial conditions in diabetic patients [10].

Materials and Methods

Animals and diets

Twenty clinically normal adult mixed-breed dogs were prepared for this experiment. Their body weight ranged from 12 to 16 kg initially.

These dogs were housed individually in the Tunisian Veterinary Medicine School, Sidi Thabet. Animals were fed once daily with 350- 400 g of commercial dry food (23% protein, 6% fat, 33% carbohydrates, 4% crude fiber and 3000 kcal/kg as energetic value; (DOGSY) from Tunisian Animal Nutrition Society) and 200 g of beef.

This food was given to all dogs daily in the morning after drinking milk. All animal were controlled when drinking milk to be sure that all the quantity given was consumed by the dogs. Water was available ad libitum for dogs throughout the duration of the experiment.

Experimental design

Each test was divided into two periods, the first 5 weeks in which the animals were treated with milk, and weeks 6 and 7 to follow the variations of all analyzed characteristics after stopping the milk treatment. All essays were achieved in the same period and under the same conditions.

Induction of diabetes

After overnight fasting, the dogs were injected by an intravenous administration of 65 mg of alloxan monohydrate (Sigma, Aldrich; Germany)/ kg of body weight [3,11]. The alloxan solution was prepared by dissolving it in normal saline at a concentration of 100 mg/ml and injected freshly after filtration. Seven days later, these animals showed a diabetic state characterized by a high fasting blood glucose (>10 mmol/l) and presence of glucose level in urine (+++).

Milk samples

Camel milk used during this study was obtained from a camel herd (camelus dromedarius) belonging the Arid Land Institute (Medenine, Tunisia) and cow milk was given from a Tunisian breed of cow housed in the Veterinary School of Medicine, Sidi Thabet, Tunisia.

Raw camel milk was delivered freshly, without any dilution, to the animals. Pasteurized milk was treated at 63°C during 30 minutes, cooled at room temperature. Boiled milk was treated at 100°C during 3 minutes after boiling and distributed after cooling at room temperature.

For all milk samples, pH and acidity were checked to monitor the freshness of milk. The gross composition of all types of milk was determined (fat, total proteins and total solids). Fat content was measured using the neusol method [12], and the total proteins concentration was determined by the Kjheldahl method using a nitrogen conversion factor of 6.36 [13]. Total solids were evaluated after drying at 105°C until a steady weight was achieved [13].

Test 1: Effect of raw camel milk on diabetic dogs

Twelve adult dogs were divided in 3 groups each one containing four dogs. Group 1 was composed of diabetic dogs receiving raw camel milk, group 2 consisted of diabetic dogs getting raw cow milk and healthy dogs (group 3) drinking camel milk and used as control. Two hundred and fifty ml of milk was given daily, fasting, in the morning for each animal during 5 weeks followed by two weeks (without milk treatment) in which all parameters were analyzed.

Intravenous glucose tolerance test: IGTT

An Intravenous Glucose Tolerance Test (IGTT) assay was performed aiming to verify the glycemic state (diabetic or not) of the animals. This test was performed on all animals (diabetic or no) after the end of the first test. Glucose was injected after an overnight fasting, by intravenous administration of 0.5 g of glucose/kg of body weight. Blood sample was drawn at each 30 min during 3 h.

Test 2: Effect of heat treatment on the anti-diabetic effect of camel milk

Two other groups composed by four diabetic dogs (groups 4 and 5) were the subject of this experiment step and were given respectively 250 ml of pasteurized camel milk (group 4) and 250 ml of boiled camel milk (group 5). Milk was given to each animal daily during five weeks.

Urine analysis

During the first week after injection of alloxan, urine samples were subjected to analyze glucosuria, proteins and ketones. These analyses were performed using Bayer Strips (Bayer Diagnostics Mfg, Bridgen, UK) for Urine analysis.

Blood samples

Blood samples were drawn from the radial vein with Vacutainer system; these samples were divided into two tubes: one for glycemic assay (enclose oxalate fluorure), other for cholesterol, TG and total proteins assays. Blood samples were realized 2 times per week during the milk treatment (5 weeks) and two weeks (weeks 6 and 7) after the end of the experiment.

Blood glucose concentrations was measured by a glucose oxidase method (Biomaghreb®, Tunis, Tunisia) using a spectrophotometer CECIL (CE 2041) at 505 nm.

Cholesterol and Triglycerides concentrations were determined by enzymatic methods (Biomaghreb®) using spectrophotometer CECIL (CE 2041) at 505 nm. Total proteins concentrations were analyzed at 546 nm.

Statistical analysis

The data were expressed as the mean ± SEM and represented the average values for the animals in the same group. These data were subjected to statistical analysis, using SAS computer software (SAS institute, 1998), to be compared between and within the experimental groups.

This test combines ANOVA with comparison of differences between the means of the treatments at the significance level of p< 0.05.


Effect of the heat treatment on the gross composition of milk samples

Milk analysis: The pH and acidity of the camel milk provided to the animals were respectively 6.41 ± 0.18 and 16.87 ± 1.035°Dornic. These characteristics for the cow milk were as follows: 6.61 ± 0.24 for pH and 17.12 ± 0.64°Dornic.

Camel milk used during this study was rich in total protein (34.15 ± 3.11 g/l) and in total solids (119.43 ± 1.84 g/l) compared with bovine milk (30.5 ± 1.95 g/l for total proteins and 104.88 ± 4.39 g/l for total solid amounts). There was no significant difference in fat among the camel and cow milk used (34.5 ± 3.1g/l in camel milk and 32.5 ± 2.12 g/l in bovine milk).

The effect of heat treatment on camel milk composition was revealed only on boiled camel milk which showed a significant decrease on fat concentration (from 37.5 ± 5 to 33.37 ± 5.18 g/l, p = 0.002).

Effect of raw camel milk compared to cow milk on diabetic dogs

After 5 weeks of treatment with raw camel milk, a significant decrease on blood glucose levels was noted; from 10.16 ± 1.16 to 5.22 ± 1.06 mmol/l (p = 0.03) in group 1 (Figure 1). This decrease was statistically significant since week 3 and showed a non significant difference in comparison with the healthy group in which Blood glucose concentrations was about 5.17 ± 0.25 mmol/l. The dogs getting cow milk showed a steady high blood glucose level (9.29 ± 0.9 mmol/l), glucosuria (+++) and proteinuria (++) (Figure 1).


Figure 1 : Group 1: Diabetic dogs treated with 250 ml of raw camel milk/ dog/ day. Group 2: Diabetic dogs treated with 250 ml of raw cow milk/ dog/day. Group 3: Healthy dogs used as control. Weeks 1 to 5: During the treatment with milk. Weeks 6 and 7: After stopping drinking milk.

Intravenous Glucose Tolerance Test (IGTT)

The results of this test are represented in Figure 2; the difference was mostly observed among the three treatments, especially among the dogs treated with raw cow milk and the two other groups. The diabetic dogs which were treated with cow milk (group 2) showed a steady diabetic state that was confirmed before injection of glucose by a high blood glucose level (8.61 ± 0.22 mmol/l) and a stability of high blood glucose level during this test (7.78 ± 0.55 mmol/l). However, in group 1 - treated with camel milk-blood glucose levels illustrated a large decrease after 60 min (from 9.07 ± 0.53 mmol/l (at 10 min) to 6.49 ± 0.9 mmol/l) and a steadiness of this parameter within the normal range (5.5 ± 0.94 mmol/l) (Figure 2); variations of blood glucose levels during the IGTT test revealed a nonsignificant difference (p > 0.05) between the animals drinking camel milk (group 1) and the healthy group (group 3).


Figure 2: Group 1: Diabetic dogs treated with raw camel milk. Group 2: Diabetic dogs treated with raw cow milk. Group 3: Healthy group.

TG, cholesterol and total proteins variations

Only TG concentrations were not influenced by the diabetic state in dogs and the treatment with camel milk (Table 1).

Total proteins (g/l) Cholesterol (mmol/l) TG (mmol/l)
Group 1 Group 2 Group 3 Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
  75.31a ± 4.68   80.38a ± 0.9 68.48b ± 1.11   6.94a ± 0.06 6.99a ± 0.58 4.17b ± 1.2   1.11 ± 0.15 1.03 ± 0.17 0.95 ± 0.27
  71.26a ± 2.46 77.35a ± 5.5 68.8b ± 1.25   6.96a ± 0.43 6.64a ± 1.31 3.98b ± 0.25   0.93 ± 0.15 1.29 ± 0.19 0.64 ± 0.22
  74.21a ± 6.39 79.87a ± 4.13 67.06b ± 2.27   6.41a ± 0.51 6.81a ± 0.21 4.71b ± 0.07   0.65 ± 0.01 1.27 ± 0.63 0.66 ± 0.15
  69.71b  ± 2.8 84.79a ± 4.4.7 67.75b ± 2.17   5.42b ± 0.48 6.78a ± 1.95 4.82b ± 0.64   0.96 ± 0.31 1.32 ± 0.07 0.74 ± 0.15
  67.08b ± 0.15 83.28a ± 2.77 64.82b ± 4.11   5.11b ± 0.72 6.83a ± 0.58 4.21b ± 0.46   0.92 ± 0.28 1.17 ± 0.25 0.92 ± 0.83
  65.44b ± 0.76 85.36a ± 1.21 65.45b ± 1.03   5.04b ± 0.8 7.08a ± 0.98 4.08b ± 0.33   1.04 ± 0.68 1.14 ± 0.33 0.9 ± 0.32
  64.19b ± 1.79 82.92a ± 2.35 64.63b ± 3.2   4.66b ± 1.17 6.71a ± 1.23 4.65b ± 0.56   0.8 ± 0.11 1.21 ± 0.52 1.01 ± 0.38
  65.2b  ± 1.58 83.25a ± 3.14 65.02b ± 1.04   4.86b ± 0.79 6.83a ± 0.42 4.51b ± 0.36   1.04 ± 0.08 1.13 ± 0.64 0.98 ± 0.62

Table 1: Weekly variations of total proteins, cholesterol and TG concentrations on groups 1, 2 and 3 during the first test.

Since the third week, dogs from group 1 showed a significant decrease on cholesterol and total proteins concentrations (p<0.05) respectively from 6.94 ± 0.06 to 5.42 ± 0.48 mmol/l and from 77.31 ± 2.68 to 68.71 ± 1.8 g/l.

Dogs from group 2 showed a stable diabetic state illustrated by high cholesterol (6.85 ± 0.93 mmol/l) and total proteins concentrations (82.83 ± 3.83 g/l).

Effect of heat treatment on the anti-diabetic effect of camel milk

Glycemic balance: During the second test, group 4 (treated with pasteurized camel milk) showed a significant decrease on blood glucose levels from 9.85 ± 1.98 to 6.3 ± 1.02 mmol/l; p < 0.05 (Figure 3). Statistical analysis revealed no significant difference between groups 1 and 4.

For these groups (1 and 4) receiving respectively raw and pasteurized camel milk, the improvement on glycemic balance was shown also after stopping to drink camel milk and illustrated by a normal range of blood glucose concentrations (5.64 ± 1.3 mmol/l) (Figure 3).


Figure 3 : Group 1: Diabetic dogs receiving 250 ml raw camel milk / dog/ day. Group 4: Diabetic dogs getting 250 ml pasteurized camel milk / dog/ day. Group 5: Diabetic dogs receiving 250 ml boiled camel milk / dog/ day. Weeks 1 to 5: During the treatment with milk. Weeks 6 and 7: After stopping drinking milk.

In this time group 5 (getting boiled camel milk) illustrated a steady diabetic state approved by high blood glucose concentrations (10.25 ± 0.68 mmol/l in average), glucosuria (+++), proteinuria (++) and ketones (++). Statistical analysis showed a significant difference between group 5 and the tow other groups (groups 1 and 4).

TG, cholesterol and total proteins variations: Only TG concentrations did not show any variations for all treatments during the experiment (Table 2). During the treatment with pasteurized camel milk, analyzed parameter illustrated a decrease on cholesterol concentrations (from 7.25 ± 1.11 to 5.18 ± 0.97 mmol /l) and on total proteins concentrations (from 74.84 ± 5.45 to 66.03 ± 3.36 g/l). Weekly variations of these parameters revealed a statistically significant decrease on cholesterol concentrations (from 7.25 ± 1.11 to 4.78 ± 1.6 mmol/l) from week 3 and on total proteins concentrations from week 4 (74.84 ± 5.45 to 67.06 ± 3.32 g/l) (Table 2).

  Total proteins (g/l) Cholesterol (mmol/l) TG (mmol/l)
  Group 1 Group 4 Group 5 Group 1 Group 4 Group 5 Group 1 Group 4 Group 5
Day 0 75.31a±4.68 74.84a±5.45 76.59a±7.21 6.94a±0.06 7.25a±1,11 7.33a±0.22 1.11±0.15 0.94±0.22 1.13±0.22
Week 1 71.26a±2.46 71.37a±4.66 72.72a±4.18 6.96a±0.43 7.52a±0,51 7.26a±1.08 0.93±0.15 0.94±0.17 0.99±0.13
Week 2 74.21a±6.39 72.10a±4.4 71.99a±5.54 6.41b±0.51 6.62b±1.14 6.8a±0.35 0.65±0.01 0.73±0.23 0.66±0.16
Week 3 69.71b ±2.8 71.87a±4.15 74.05a±6.89 5.42b±0.48 4.78b±1.6 7.2a±0.39 0.96±0.31 0.74±0.11 0.96±0.31
Week 4 67.08b±0.15 67.06b±3.32 71.06a±6.97 5.11b±0.72 5.4b±0.24 6.77a±0.21 0.92±0.28 0.83±0.24 0.92±0.28
Week 5 65.44b±0.76 66.03b±3.36 71.04a±8.2 5.04b±0.8 5.18b±0.97 6.77a±0.4 1.04±0.68 0.96±0.33 1 ±0.56
Week 6 64.19b±1.79 64.95b±4.43 70.53a±6.06 4.66b±1.17 5.57b±0.66 6.99a±0.49 0.8±0.11 0.91±0.08 0.88±0.16
Week 7 65.2b ±1.58 62.77b±3.96 69.73a±4.9 4.86b±0.79 5.51b±0.19 7a±0.55 1.04±0.08 0.93±0.04 1.01±0.08

Table 2: Effect of heat treatment on the weekly variations of total proteins, cholesterol and TG concentrations on diabetic dogs.

A normal range of total proteins and cholesterol was investigated by the end of camel milk treatment and all dogs showed a clinically healthy state.

When receiving boiled camel milk, diabetic dogs did not show any improvement in proteins profile (72.03 ± 6.49 g/l) and the same result was illustrated in lipids profile by high cholesterol levels (about 7.02 ± 0.44 mmol/l) (Table 2).


The efficacy of raw and pasteurized camel milk on glycemic control, and lipid and proteins profile was evaluated in this project using Alloxan-induced diabetic dogs.

A single dose of alloxan injected to dogs was able to produce a reproducible model of diabetes mellitus that had minimal beta cell activity, and elevated glucose, total proteins and cholesterol levels. Alloxan injection causes a toxic effect on kidney and liver in addition to the pancreas as investigated by other study on alloxan induceddiabetes in dogs [5].

Diabetes in dogs is generally associated, in addition to high blood glucose levels, with an increase of total proteins concentrations [14,15] which was illustrated in our study in all dogs after injection of alloxan and especially in dogs from group 2 treated with cow milk during the trial (82.83 ± 3.83 g/l). This can be due to the toxicity of alloxan on the proximal straight renal tube as reported by Watanabe et al. [16].

A significant decrease on blood glucose levels was well showed on dogs treated with camel milk. This decrease was statistically illustrated since week 3 and associated to a decline of total proteins and cholesterol concentrations and a steadiness of this state since week 3 and after stopping to drink camel milk.

This hypoglycemic effect of camel milk may be due to the high level of insulin in comparison to cow milk [17], whereas in our assay, the results cannot be due to this particularity because the efficacy of camel milk on glycemic control was observed also after stopping to drink camel milk (group 1).

This therapeutic effect of camel milk was traditionally described and a good glycemic control or anabolic effect of this product was mentioned [9,18]. It may be explained by the particularity and properties of camel milk in comparison with milk from other species [19].

High mineral content on vitamin C intake may act as antioxidant there by removing free radicals, which may provide an additional benefit to the animals treated with camel milk [20]. It may be explained by the particularity and properties of camel milk in comparison with milk from other species, such as the absence of β-lactoglobulin, the high amount of polyunsaturated fatty acids (C18:1-C18: 3), and the high amount of vitamin B3 [21] and also some particularities of camel immunoglobulin, such as their small size and weight which offers enormous potential to camel milk. Also camel milk immunoglobulin, of relatively small size and weight, might offer an interplay with host cell protein leading to an induction of regulatory cells and finally leading to a downward regulation of immune system and β-cell salvage [22,23].

The therapeutic efficacy of camel milk on Alloxan-induced diabetic dogs was well shown in the first test (raw camel milk) and after pasteurization which explain that this treatment did not have any effect on the camel milk composition and the anti-diabetic property. Some previous study showed that there was no change on whey camel milk proteins when treated at same temperature [24,25].

Except this effectiveness is sensitive to high temperature especially after boiling (100°C); the active substance(s) responsible on this effect may be sensitive to high temperature. El-Agamy, 2000 reported that after heating up to 100°C the effects were less on camel milk α-lactalbumin and Ig G compared with cow milk however a completely denaturation of camel lactoferrine was shown at this temperature.

Also some previous study [26,27] reported that heat treatment of camel milk allowed to a demineralization of the caseins micelle and to an increase of soluble Ca concentrations.


From the results obtained it can be concluded that:

(a) Raw camel milk can be used as solution to treat alloxan - induced diabetic dogs.

(b) This therapeutic property of camel milk was losing after treatment of camel at 100°C (boiled camel milk).

(c) Pasteurization can be used not only to store the camel milk but also to preserve this therapeutic particularity.

More study was actually warranted to identify the active principle responsible of this remedial property in camel milk.


We are thankful to Mr Barmat Ahmed and Mr Benbelgacem Hamed for their help in providing camel milk. We are also grateful to Dr. Barhoumi Kamel for his serious help during the experiment.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • International Conference on Internal Medicine May 21-22, 2018 Osaka, Japan
    May 21-22, 2018 Osaka, Japan
  • International conference on Fitness and Expo June 04-05, 2018 Baltimore, Maryland, USA
    June 4-5, 2018 Baltimore, USA
  • Annual Congress on Research and Innovations in Medicine July 02-03, 2018 Bangkok, Thailand
    July 02-03, 2018 Bangkok, Thailand
  • International Conference on Medical and Health Science August 24-25, 2018 Tokyo, JAPAN
    August 24-25, 2018 Tokyo, Japan

Article Usage

  • Total views: 12058
  • [From(publication date):
    May-2012 - Apr 22, 2018]
  • Breakdown by view type
  • HTML page views : 8275
  • PDF downloads : 3783

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version